Can HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase inhibitors, commonly referred to as statins, increase the coronary artery calcium (CAC) score?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Yes, statins can potentially increase coronary calcium scores despite their beneficial effects on cardiovascular health. The most recent and highest quality study, published in 2023 1, found that long-term statin therapy is associated with severe coronary artery calcification. This study demonstrated that the duration of statin therapy was associated with greater odds of having increased coronary artery calcium scores, with an odds ratio of 5.30 for those taking statins for more than 10 years.

Key Findings

  • The study found that statin duration of zero served as the referent control, and the relationship between statin duration and coronary artery calcium scores remained significant after multivariate adjustment 1.
  • Another study published in 2021 2 also found that statins do not decrease coronary artery calcium and may increase existing calcification or its density.
  • The benefits of statin therapy in reducing cardiovascular events and mortality are well established, and the increase in coronary calcium scores should not be interpreted as disease progression or treatment failure 3, 4.

Clinical Implications

  • Patients should continue their prescribed statin therapy even if their calcium score increases, as the benefits of appropriate statin therapy far outweigh concerns about increased coronary calcification.
  • Healthcare providers should consider the context of overall cardiovascular risk reduction when interpreting coronary calcium scores in patients on statins, rather than focusing solely on changes in calcification alone.
  • The presence and severity of coronary artery calcium can identify patients most likely to benefit from statins for the primary prevention of cardiovascular diseases 4.

Recommendations

  • Statin therapy should be continued in patients with increased coronary calcium scores, as the benefits of statin therapy in reducing cardiovascular events and mortality outweigh the potential increase in coronary calcification.
  • Healthcare providers should individualize treatment decisions based on a patient's overall cardiovascular risk profile, rather than relying solely on coronary calcium scores.

References

4
Research

Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring.

Journal of the American College of Cardiology, 2018

Related Questions

What are the cardiology recommendations for a patient with a total Computed Tomography (CT) coronary calcium score of mild hypercalcification?
At what coronary artery calcium score should statin therapy be initiated?
At what level of coronary artery calcium score is statin (HMG-CoA reductase inhibitor) therapy recommended?
Is Coronary Artery Calcium (CAC) scoring beneficial after initiating statin (HMG-CoA reductase inhibitor) therapy?
Are coronary calcifications reassuring in a young male athlete?
What is the differential diagnosis for a 71-year-old woman with bilateral axillary lymphadenopathy (enlarged lymph nodes in the axillary region), cervical lymphadenopathy (enlarged lymph nodes in the neck), and splenomegaly (enlarged spleen), with a history of hypertension and cataracts, and laboratory results showing anemia (low red blood cell count) and lymphocytosis (elevated lymphocyte count)?
What is the diagnosis for a 2-year-old boy with a history of recurrent skin infections, including a perianal abscess and lymphadenitis, presenting with a painful, indurated, fluctuant mass on his right arm, with abnormal dihydrorhodamine flow cytometry and culture growth of Serratia marcescens?
What is the role of Bactrim (Trimethoprim/Sulfamethoxazole) in Spontaneous Bacterial Peritonitis (SBP) prophylaxis?
Can Bactrim (Trimethoprim/Sulfamethoxazole) cause hyponatremia?
What vaccinations are recommended for a 6-week-old former preterm (premature) infant, born at 31 weeks gestation, with a history of brief oxygen supplementation via Continuous Positive Airway Pressure (CPAP) and nasal cannula, and phototherapy for hyperbilirubinemia (jaundice)?
What infections would Ciprofloxacin (ciprofloxacin) cover?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question